X
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.fiercepharma.com/marketing/heels-pulmonary-arterial-hypertension-drug-nod-merck-launches-outnumber-pah-campaign
https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-mercks-blood-pressure-therapy-2024-03-26/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761363
https://endpts.com/merck-unwraps-full-phiii-data-on-the-centerpiece-from-its-11-5b-acceleron-buyout-acc23/
https://www.businesswire.com/news/home/20230306005323/en/Merck%E2%80%99s-Investigational-Activin-Signaling-Inhibitor-Sotatercept-Improved-Six-Minute-Walk-Distance-by-40.8-Meters-at-Week-24-Versus-Placebo-in-Adults-with-Pulmonary-Arterial-Hypertension-on-Background-Therapy
https://www.fiercebiotech.com/biotech/mercks-cardiovascular-future-takes-shape-sotatercept-overachieves-and-oral-pcsk9-passes
https://www.fool.com/investing/2022/10/26/is-merck-moving-toward-another-blockbuster-drug-la/
https://www.fiercebiotech.com/biotech/merck-nails-phase-3-sotatercept-win-year-after-acquiring-it-acceleron
https://www.fiercepharma.com/pharma/buying-acceleron-for-11b-a-good-fit-for-merck-to-diversify-from-keytruda-but-antitrust
https://www.fiercebiotech.com/biotech/mystery-suitor-lines-up-11b-acceleron-acquisition-report
https://endpts.com/merck-emerges-as-lead-bidder-in-potential-acceleron-buyout-with-deal-possible-this-week-report/
https://www.businesswire.com/news/home/20201214005111/en/Acceleron-Receives-Orphan-Designation-from-the-European-Commission-EC-for-Sotatercept-in-Pulmonary-Arterial-Hypertension-PAH
https://www.biospace.com/article/releases/acceleron-announces-clinical-trial-updates-preclinical-presentation-on-sotatercept-in-pulmonary-arterial-hypertension-at-the-2020-american-heart-association-aha-scientific-sessions/
https://www.biospace.com/article/releases/acceleron-completes-target-enrollment-in-the-pulsar-phase-2-trial-of-sotatercept-in-pulmonary-arterial-hypertension/
Market Place
Share 
